The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
Open accessAbstract
INTRODUCTION: Comorbidities significantly influence the clinical course of idiopathic pulmonary fibrosis (IPF). However, their prognostic impact is not fully understood. We therefore aimed to determine the impact of comorbidities, as individual and as whole, on survival in IPF. METHODS: The database of a tertiary referral centre for interstitial lung diseases was reviewed for comorbidities, their treatments, their frequency and survival in IPF patients. RESULTS: 272 patients were identified of which 12% had no, 58% 1-3 and 30% 4-7 comorbidities, mainly cardiovascular, pulmonary and oncologic comorbidities. Median survival according to the frequency of comorbidities differed significantly with 66 months for patients without comorbidities, 48 months when 1-3 comorbidities were reported and 35 months when 4-7 comorbidities were prevalent (p = 0.004). A multivariate Cox proportional hazard analyses identified other cardiac diseases and lung cancer as significant predictors of death, gastro-oesophageal reflux disease (GERD) and diastolic dysfunction had a significant positive impact on survival. A significant impact of comorbidities associated therapies on survival was not discovered. This included the use of proton pump inhibitors at baseline, which was not associated with a survival benefit (p = 0.718). We also established a predictive tool for highly prevalent comorbidities, termed IPF comorbidome which demonstrates a new relationship of IPF and comorbidities. CONCLUSION: Comorbidities are frequent in IPF patients. Some comorbidities, especially lung cancer, mainly influence survival in IPF, while others such as GERD may inherit a more favourable effect. Moreover, their cumulative incidence impacts survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Self-citationA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0034oc · Cited by 1,275
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunes, H., Brillet, P.-Y., Delaval, P., Devouassoux, G., Tillie-Leblond, I., Israel-Biet, D., Court-Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,004
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894 · cited 1×
“Telomerase mutations in TERT or TERC which cause telomere shortening increase the susceptibility to IPF [33] and there is also considerable evidence that telomere attrition is associated with, and possibly causative of cancer [34] as well as of emphysema [35].”
BackgroundPrevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Idiopathic Pulmonary Fibrosis and Emphysema
Mejía, M., Carrillo, G., Rojas-Serrano, J., Estrada, A., Suárez, T., Alonso, D., Barrientos, E., Gaxiola, M., Navarro, C., & Selman, M. (2009) · Chest · doi:10.1378/chest.08-2306 · Cited by 468
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Raghu, G., Amatto, V. C., Behr, J., & Stowasser, S. (2015) · European Respiratory Journal · doi:10.1183/13993003.02316-2014 · Cited by 463
Lee, J. S., Ryu, J. H., Elicker, B. M., Lydell, C. P., Jones, K. D., Wolters, P. J., King, T. E., & Collard, H. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0138oc · Cited by 437
Lee, J. S., Collard, H. R., Anstrom, K. J., Martinez, F. J., Noth, I., Roberts, R. S., Yow, E., & Raghu, G. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70105-x · Cited by 413
Hamada, K., Nagai, S., Tanaka, S., Handa, T., Shigematsu, M., Nagao, T., Mishima, M., Kitaichi, M., & Izumi, T. (2007) · Chest · doi:10.1378/chest.06-1466 · Cited by 390
Pulmonary rehabilitation for interstitial lung disease
Dowman, L., Hill, C. J., & Holland, A. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006322.pub3 · Cited by 381
Epidemiology of idiopathic pulmonary fibrosis
Ley, B., & Collard, H. (2013) · Clinical Epidemiology · doi:10.2147/clep.s54815 · Cited by 321
Obstructive Sleep Apnea Is Common in Idiopathic Pulmonary Fibrosis
Lancaster, L. H., Mason, W. R., Parnell, J. A., Rice, T. W., Loyd, J. E., Milstone, A. P., Collard, H. R., & Malow, B. A. (2009) · Chest · doi:10.1378/chest.08-2776 · Cited by 321
Cumulative incidence of and predictive factors for lung cancer in IPF
OZAWA, Y., SUDA, T., NAITO, T., ENOMOTO, N., HASHIMOTO, D., FUJISAWA, T., NAKAMURA, Y., INUI, N., NAKAMURA, H., & CHIDA, K. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01547.x · Cited by 314
The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
Tomassetti, S., Gurioli, C., Ryu, J. H., Decker, P. A., Ravaglia, C., Tantalocco, P., Buccioli, M., Piciucchi, S., Sverzellati, N., Dubini, A., et al. (2015) · Chest · doi:10.1378/chest.14-0359 · Cited by 314
Telomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Patel, N. M., Lederer, D. J., Borczuk, A. C., & Kawut, S. M. (2007) · Chest · doi:10.1378/chest.06-3087 · Cited by 248
Behr, J., Kreuter, M., Hoeper, M. M., Wirtz, H., Klotsche, J., Koschel, D., Andreas, S., Claussen, M., Grohé, C., Wilkens, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00217614 · Cited by 247
Self-citationAntacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
Kreuter, M., Wuyts, W., Renzoni, E., Koschel, D., Maher, T. M., Kolb, M., Weycker, D., Spagnolo, P., Kirchgaessler, K.-U., Herth, F. J. F., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00067-9 · Cited by 218
Self-citationPrevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis
Nathan, S. D., Basavaraj, A., Reichner, C., Shlobin, O. A., Ahmad, S., Kiernan, J., Burton, N., & Barnett, S. D. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.02.008 · Cited by 205
Quality of life of idiopathic pulmonary fibrosis patients
Vries, J. D., Kessels, B. L. J., & Drent, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17509540 · Cited by 193
Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease
Huppmann, P., Sczepanski, B., Boensch, M., Winterkamp, S., Schönheit-Kenn, U., Neurohr, C., Behr, J., & Kenn, K. (2013) · European Respiratory Journal · doi:10.1183/09031936.00081512 · Cited by 186
How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard, C., Hilberg, O., & Bendstrup, E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.01.008 · Cited by 180
Pulmonary Rehabilitation in Interstitial Lung Disease
Koltharkar, M. (2021) · International Journal of Cardiovascular Research · Cited by 173
Common pathways in idiopathic pulmonary fibrosis and cancer
Vancheri, C. (2013) · European Respiratory Review · doi:10.1183/09059180.00003613 · Cited by 166
Association Between Pulmonary Fibrosis and Coronary Artery Disease
Kizer, J. R., Zisman, D. A., Blumenthal, N. P., Kotloff, R. M., Kimmel, S. E., Strieter, R. M., Arcasoy, S. M., Ferrari, V. A., & Hansen-Flaschen, J. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.5.551 · Cited by 150
Sleep-Related Breathing Disorders in Patients with Idiopathic Pulmonary Fibrosis
Mermigkis, C. M., Chapman, J. T., Golish, J. A., Mermigkis, D., Budur, K., Kopanakis, A., Polychronopoulos, V. S., Burgess, R. C., & Foldvary‐Schaefer, N. (2007) · Lung · doi:10.1007/s00408-007-9004-3 · Cited by 142
Sleep Quality and Health-Related Quality of Life in Idiopathic Pulmonary Fibrosis
Krishnan, V., McCormack, M. C., Mathai, S. C., Agarwal, S., Richardson, B., Horton, M. R., Polito, A. J., Collop, N. A., & Danoff, S. K. (2008) · CHEST Journal · doi:10.1378/chest.08-0173 · Cited by 101
Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
Kreuter, M., Ehlers-Tenenbaum, S., Schaaf, M., Oltmanns, U., Palmowski, K., Hoffmann, H., Schnabel, P. A., Heußel, C. P., Puderbach, M., Herth, F. J. F., et al. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 92
Self-citationHyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes
Hunt, W. R., Zughaier, S. M., Guentert, D. E., Shenep, M. A., Koval, M. H., McCarty, N. A., & Hansen, J. M. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00224.2013 · Cited by 76
Kreuter, M., Wijsenbeek, M. S., Vašáková, M., Spagnolo, P., Kolb, M. R. J., Costabel, U., Weycker, D. A., Kirchgaessler, K.-U., & Maher, T. M. (2016) · European Respiratory Journal · doi:10.1183/13993003.02087-2015 · Cited by 73
Self-citationThe Role of Gastroesophageal Reflux and Microaspiration in Idiopathic Pulmonary Fibrosis
Lee, J. S. (2014) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000031 · Cited by 68
Calado, R. T., & Young, N. S. (2012) · F1000 Medicine Reports · doi:10.3410/m4-8 · Cited by 67
Mertens, V., Blondeau, K., Vanaudenaerde, B. M., Vos, R., Farré, R., Pauwels, A., Verleden, G. M., Raemdonck, D. E. V., Dupont, L., & Sifrim, D. A. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d47dc4 · Cited by 63
Papadopoulos, C. E., Pitsiou, G., Karamitsos, T. D., Karvounis, H. I., Kontakiotis, T., Giannakoulas, G. A., Efthimiadis, G. K., Argyropoulou, P., Parharidis, G., & Bouros, D. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00102107 · Cited by 60
Colombi, D., Dinkel, J., Weinheimer, O., Obermayer, B., Buzan, T., Nabers, D., Bauer, C. C., Oltmanns, U., Palmowski, K., Herth, F. J. F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130653 · Cited by 51
Self-citationKreuter, M., Wijsenbeek, M. S., Vašáková, M., Spagnolo, P., Kolb, M. R. J., Costabel, U., Weycker, D. A., Kirchgaessler, K.-U., & Maher, T. M. (2016) · European Respiratory Journal · doi:10.1183/13993003.01482-2016 · Cited by 22
Self-citationAn Important Step Forward, but Still a Way to Go
Wuyts, W. A., Bonella, F., Costabel, U., Cottin, V., Kreuter, M., Poletti, V. E., & Spagnolo, P. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1763le · Cited by 6
Self-citation
Cited by
Raghu, G., Remy-Jardin, M., Richeldi, L., Thomson, C. C., Inoue, Y., Johkoh, T., Kreuter, M., Lynch, D. A., Maher, T. M., Martinez, F. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0399st · Cited by 2,957
Self-citationMartinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Idiopathic pulmonary fibrosis: state of the art for 2023
Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359
Self-citationPirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Lancaster, L. H., de Andrade, J. A., Zibrak, J. D., Padilla, M. L., Albera, C., Nathan, S. D., Wijsenbeek, M. S., Stauffer, J. L., Kirchgaessler, K.-U., & Costabel, U. (2017) · European Respiratory Review · doi:10.1183/16000617.0057-2017 · Cited by 295
The therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi, V., Chaudhuri, N., Torrisi, S. E., Kahn, N., Müller, V., & Kreuter, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0021-2019 · Cited by 265
Self-citation
Metadata
- Authors
- Kreuter, M., Ehlers-Tenenbaum, S., Palmowski, K., Bruhwyler, J., Oltmanns, U., Muley, T., Heussel, C. P., Warth, A., Kolb, M., & Herth, F. J. F.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-03-29
- Volume
- 11
- Issue
- 3
- Pages
- e0151425
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2328539250
- Cited by
- 351
- References
- 43
- FWCI
- 28.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.